PIMCO總回報主動型ETF BOND 深 滬
等待開盤 10-02 09:30:00 美东时间
93.18
+0.230
+0.25%
華盛通- 最 高93.2605
- 今 開93.25
- 成交量 39.87万股
- 最 低 93.05
- 昨 收 92.95
- 總市值 56.85亿
- 52周最高 94.1431
- 市盈率 靜 --
- 換手率 0.65%
- 52周最低 86.03
- 委 比 72.71%
- 總股本 6101.00万
- 歷史最高 95.75
- 量 比 1.43
- 振 幅 0.23%
- 歷史最低 67.3616
- 每 手 1
- 風險率 1.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CG Oncology Announced Updated Data On BOND-003 Cohort C Showing 12 Additional Patients With High Risk Non-muscle Invasive Bladder Cancer Were In Complete Response At 24 Months, With Complete Response Rate Of 41.8%
Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG)
09-05 19:04
SHO-BOND Holdings Announces Director Changes for Strategic Realignment
SHO BOND Holdings Co ( ($JP:1414) ) has issued an update. SHO-BOND Holdings Co....
08-18 14:52
Trump Stands by Attorney General Amid Jeffrey Epstein Controversy: 'Let Pam Bondi Do Her Job — She's Great'
In the wake of rumors surrounding Attorney General Pam Bondi's possible resignation, President Trump has stepped forward to defend her.
07-14 02:31
This Corner Of The ETF Market Is About To Explode To $2 Trillion
Active fixed income strategies are poised for massive growth as investors demand flexibility and alpha generation in a volatile market. Three top ETFs leading the way are JPST, BOND, and FIXP.
05-21 03:43
乐普生物-B现涨超7% CG Oncology溶瘤病毒疗法III期试验数据亮眼
乐普生物-B（02157）早盘上涨7.17%，现报4.93港元，成交额4114.59万港元。 4月28日，CG Oncology在美国泌尿外科学会年会上公布...
04-30 10:10
CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
CG Oncology shared new Phase 3 trial results showing durable responses and strong patient compliance in high-risk bladder cancer treatment at AUA 2025.
04-28 23:14
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues MINNEAPOLIS, April 24, 2025 /PRNewswire/ -- Bio-Techne C...
04-24 19:00
公司簡介
公司名稱
|
PIMCO总回报主动型ETF
|
行業分類
|
--
|
業務描述
|
Exists as exchange Traded Fund
|
CG Oncology Announced Updated Data On BOND-003 Cohort C Showing 12 Additional Patients With High Risk Non-muscle Invasive Bladder Cancer Were In Complete Response At 24 Months, With Complete Response Rate Of 41.8%
Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG)
09-05 19:04
SHO-BOND Holdings Announces Director Changes for Strategic Realignment
SHO BOND Holdings Co ( ($JP:1414) ) has issued an update. SHO-BOND Holdings Co....
08-18 14:52
Trump Stands by Attorney General Amid Jeffrey Epstein Controversy: 'Let Pam Bondi Do Her Job — She's Great'
In the wake of rumors surrounding Attorney General Pam Bondi's possible resignation, President Trump has stepped forward to defend her.
07-14 02:31
This Corner Of The ETF Market Is About To Explode To $2 Trillion
Active fixed income strategies are poised for massive growth as investors demand flexibility and alpha generation in a volatile market. Three top ETFs leading the way are JPST, BOND, and FIXP.
05-21 03:43
乐普生物-B现涨超7% CG Oncology溶瘤病毒疗法III期试验数据亮眼
乐普生物-B（02157）早盘上涨7.17%，现报4.93港元，成交额4114.59万港元。 4月28日，CG Oncology在美国泌尿外科学会年会上公布...
04-30 10:10
CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
CG Oncology shared new Phase 3 trial results showing durable responses and strong patient compliance in high-risk bladder cancer treatment at AUA 2025.
04-28 23:14
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues MINNEAPOLIS, April 24, 2025 /PRNewswire/ -- Bio-Techne C...
04-24 19:00
年度
|
派息內容
| 派息日期 |
0.40
|
2025-09-04
| |
0.40
|
2025-08-05
| |
0.39
|
2025-07-03
| |
0.40
|
2025-06-04
| |
0.40
|
2025-05-05
| |
0.38
|
2025-04-03
| |
0.38
|
2025-03-05
| |
0.39
|
2025-02-05
| |
0.39
|
2025-01-03
| |
0.39
|
2024-12-04
| |
0.39
|
2024-11-05
| |
0.39
|
2024-10-03
| |
0.39
|
2024-09-05
| |
0.39
|
2024-08-05
| |
0.37
|
2024-07-03
| |
0.38
|
2024-06-05
| |
0.38
|
2024-05-06
| |
0.37
|
2024-04-04
| |
0.36
|
2024-03-06
| |
0.34
|
2024-02-06
| |
0.34
|
2024-01-03
| |
0.32
|
2023-12-06
| |
0.32
|
2023-11-06
| |
0.34
|
2023-10-05
| |
0.33
|
2023-09-07
| |
0.29
|
2023-08-04
| |
0.33
|
2023-07-07
| |
0.31
|
2023-06-06
| |
0.29
|
2023-05-04
| |
0.30
|
2023-04-06
| |
0.29
|
2023-03-06
| |
0.28
|
2023-02-06
| |
0.29
|
2023-01-04
| |
0.28
|
2022-12-06
| |
0.27
|
2022-11-04
| |
0.27
|
2022-10-06
| |
0.27
|
2022-09-07
| |
0.27
|
2022-08-04
| |
0.26
|
2022-07-07
| |
0.25
|
2022-06-06
| |
0.25
|
2022-05-05
| |
0.24
|
2022-04-06
| |
0.23
|
2022-03-04
| |
0.23
|
2022-02-04
| |
0.23
|
2022-01-04
| |
0.23
|
2021-12-06
| |
0.23
|
2021-11-04
| |
0.24
|
2021-10-06
| |
0.24
|
2021-09-07
| |
0.24
|
2021-08-05
| |
0.24
|
2021-07-07
| |
0.24
|
2021-06-04
| |
0.24
|
2021-05-06
| |
0.23
|
2021-04-07
| |
0.23
|
2021-03-04
| |
0.23
|
2021-02-04
| |
0.23
|
2021-01-05
| |
0.23
|
2020-12-04
| |
0.23
|
2020-11-05
| |
0.23
|
2020-10-06
| |
0.23
|
2020-09-04
| |
0.24
|
2020-08-06
| |
0.25
|
2020-07-07
| |
0.24
|
2020-06-04
| |
0.26
|
2020-05-06
| |
0.28
|
2020-04-06
| |
0.29
|
2020-03-05
| |
0.29
|
2020-02-06
| |
0.29
|
2020-01-03
| |
0.29
|
2019-12-05
| |
0.30
|
2019-11-06
| |
0.30
|
2019-10-04
| |
0.30
|
2019-09-06
| |
0.31
|
2019-08-06
| |
0.30
|
2019-07-05
| |
0.30
|
2019-06-06
| |
0.30
|
2019-05-06
| |
0.31
|
2019-04-04
| |
0.32
|
2019-03-06
| |
0.32
|
2019-02-06
| |
0.30
|
2019-01-03
| |
0.32
|
2018-12-06
| |
0.32
|
2018-11-06
| |
0.30
|
2018-10-04
| |
0.30
|
2018-09-07
| |
0.29
|
2018-08-06
| |
0.30
|
2018-07-06
| |
0.30
|
2018-06-06
| |
0.29
|
2018-05-04
| |
0.35
|
2018-04-05
| |
0.22
|
2018-03-06
| |
0.27
|
2018-02-06
| |
0.27
|
2018-01-03
| |
0.28
|
2017-12-06
| |
0.28
|
2017-11-06
| |
0.29
|
2017-10-05
| |
0.29
|
2017-09-08
| |
0.26
|
2017-08-07
| |
0.23
|
2017-07-10
| |
0.23
|
2017-06-07
| |
0.20
|
2017-05-05
| |
0.24
|
2017-04-07
| |
0.23
|
2017-03-07
| |
0.25
|
2017-02-07
| |
0.68
|
2017-01-04
| |
0.24
|
2016-12-07
| |
0.19
|
2016-11-07
| |
0.33
|
2016-10-07
| |
0.30
|
2016-09-08
| |
0.24
|
2016-08-05
| |
0.19
|
2016-07-08
| |
0.12
|
2016-06-07
| |
0.16
|
2016-05-06
| |
0.16
|
2016-04-07
| |
0.16
|
2016-03-07
| |
0.20
|
2016-02-05
| |
1.14
|
2016-01-05
| |
0.39
|
2015-12-07
| |
0.39
|
2015-11-06
| |
0.39
|
2015-10-06
| |
0.37
|
2015-09-04
| |
0.30
|
2015-08-06
| |
0.30
|
2015-07-07
| |
0.30
|
2015-06-04
| |
0.22
|
2015-05-06
| |
0.18
|
2015-04-07
| |
0.16
|
2015-03-05
| |
0.17
|
2015-02-05
| |
1.70
|
2015-01-05
| |
1.12
|
2014-12-04
| |
0.40
|
2014-11-06
| |
0.28
|
2014-10-06
| |
0.30
|
2014-09-05
| |
0.28
|
2014-08-06
| |
0.05
|
2014-07-07
| |
0.05
|
2014-06-05
| |
0.05
|
2014-05-06
| |
0.05
|
2014-04-04
| |
0.05
|
2014-03-06
| |
0.10
|
2014-02-06
| |
0.14
|
2014-01-03
| |
0.44
|
2013-12-17
| |
0.19
|
2013-12-05
| |
0.20
|
2013-11-06
| |
0.25
|
2013-10-04
| |
0.30
|
2013-09-06
| |
0.25
|
2013-08-06
| |
0.22
|
2013-07-05
| |
0.22
|
2013-06-06
| |
0.21
|
2013-05-06
| |
0.18
|
2013-04-04
| |
0.17
|
2013-03-06
| |
0.17
|
2013-02-06
| |
0.18
|
2013-01-03
| |
0.88
|
2012-12-18
| |
0.20
|
2012-12-06
| |
0.20
|
2012-11-06
| |
0.19
|
2012-10-04
| |
0.20
|
2012-09-07
| |
0.18
|
2012-08-06
| |
0.21
|
2012-07-06
| |
0.20
|
2012-06-06
| |
0.18
|
2012-05-04
| |
0.12
|
2012-04-05
|
